Target Name: KRT18P28
NCBI ID: G343326
Other Name(s): Keratin 18 pseudogene 28 | keratin 18 pseudogene 28

KRT18P28: A Potential Drug Target and Biomarker

Keratin 18 (K18) pseudogene 28 (KRT18P28) is a non-coding DNA sequence located on chromosome 14q32. It is a potential drug target and biomarker for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

The K18 gene is a member of the keratin gene family, which is involved in the production of the protein keratin, which is a component of hair, nails, and other tissues. K18 has been implicated in various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

KRT18P28 is a non-coding DNA sequence that is located on chromosome 14q32. It is a potential drug target and biomarker for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

One of the unique features of KRT18P28 is its expression in various tissues and its potential involvement in different biological processes. KRT18P28 has been shown to be expressed in various tissues, including skin, hair, nails, and fetal tissues. It has also been associated with various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

In addition to its potential involvement in diseases, KRT18P28 also has the potential to serve as a biomarker. The expression of KRT18P28 has been shown to be associated with various diseases, including cancer and neurodegenerative diseases. By using KRT18P28 as a biomarker, researchers can monitor the progression of these diseases and determine the effectiveness of different treatments.

KRT18P28 is also a potential drug target for various diseases. Its unique expression in different tissues and its association with various diseases make it an attractive candidate for drug development. For example, KRT18P28 has been shown to be involved in the development and progression of cancer, autoimmune disorders, and neurodegenerative diseases. By targeting KRT18P28, researchers can develop new treatments for these diseases and improve patient outcomes.

In conclusion, KRT18P28 is a non-coding DNA sequence that is located on chromosome 14q32. It is a potential drug target and biomarker for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Its unique expression in various tissues and its potential involvement in different biological processes make it an attractive candidate for drug development. Further research is needed to fully understand the role of KRT18P28 in diseases and to develop new treatments.

Protein Name: Keratin 18 Pseudogene 28

More Common Targets

KRT18P29 | KRT18P31 | KRT18P33 | KRT18P34 | KRT18P4 | KRT18P40 | KRT18P41 | KRT18P42 | KRT18P44 | KRT18P48 | KRT18P49 | KRT18P5 | KRT18P50 | KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P